Jafari Maskouni S, Bavi Behbahani H, Alipour M, Javid A, Fayazfar F, Tofighzadeh P
Front Nutr. 2024; 11:1458560.
PMID: 39600724
PMC: 11588489.
DOI: 10.3389/fnut.2024.1458560.
Darzi M, Rouhani M, Keshavarz S
Front Nutr. 2023; 10:1219976.
PMID: 37794969
PMC: 10546620.
DOI: 10.3389/fnut.2023.1219976.
Acharya D, Nilmanat K, Boonyasopun U
Belitung Nurs J. 2023; 9(4):359-368.
PMID: 37645580
PMC: 10461162.
DOI: 10.33546/bnj.2691.
Habas Sr E, Eledrisi M, Khan F, Elzouki A
Cureus. 2021; 13(7):e16388.
PMID: 34408941
PMC: 8362860.
DOI: 10.7759/cureus.16388.
Xu W, Gong L, Lu J, Tang W
Exp Ther Med. 2020; 20(4):3237-3243.
PMID: 32855693
PMC: 7444362.
DOI: 10.3892/etm.2020.9044.
A comparative analysis of the efficacy and safety of paricalcitol versus other vitamin D receptor activators in patients undergoing hemodialysis: A systematic review and meta-analysis of 15 randomized controlled trials.
Geng X, Shi E, Wang S, Song Y
PLoS One. 2020; 15(5):e0233705.
PMID: 32470067
PMC: 7259607.
DOI: 10.1371/journal.pone.0233705.
Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis.
Liu Y, Liu L, Jia Y, Wu M, Sun Y, Ma F
Drug Des Devel Ther. 2019; 13:999-1009.
PMID: 30992658
PMC: 6445244.
DOI: 10.2147/DDDT.S176257.
Stroke risk and outcomes in patients with chronic kidney disease or end-stage renal disease: Two nationwide studies.
Cherng Y, Lin C, Shih C, Hsu Y, Yeh C, Hu C
PLoS One. 2018; 13(1):e0191155.
PMID: 29329323
PMC: 5766135.
DOI: 10.1371/journal.pone.0191155.
Dialysis: A Review of the Mechanisms Underlying Complications in the Management of Chronic Renal Failure.
Vadakedath S, Kandi V
Cureus. 2017; 9(8):e1603.
PMID: 29067226
PMC: 5654453.
DOI: 10.7759/cureus.1603.
Through the Patients' Eyes: The Experience of End-Stage Renal Disease Patients Concerning the Provided Nursing Care.
Stavropoulou A, Grammatikopoulou M, Rovithis M, Kyriakidi K, Pylarinou A, Markaki A
Healthcare (Basel). 2017; 5(3).
PMID: 28754014
PMC: 5618164.
DOI: 10.3390/healthcare5030036.
Male Sexual Dysfunction and Chronic Kidney Disease.
Edey M
Front Med (Lausanne). 2017; 4:32.
PMID: 28382300
PMC: 5360730.
DOI: 10.3389/fmed.2017.00032.
Are non-cardiac surgeries safe for dialysis patients? - A population-based retrospective cohort study.
Cherng Y, Liao C, Chen T, Xiao D, Wu C, Chen T
PLoS One. 2013; 8(3):e58942.
PMID: 23516581
PMC: 3597566.
DOI: 10.1371/journal.pone.0058942.
Renal transplant improves pulmonary hypertension in patients with end stage renal disease.
Savas Bozbas S, Kanyilmaz S, Akcay S, Bozbas H, Altin C, Karacaglar E
Multidiscip Respir Med. 2012; 6(3):155-60.
PMID: 22959121
PMC: 3463070.
DOI: 10.1186/2049-6958-6-3-155.
Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?.
Yoo H, Martin L, Kochi A, Rodrigues-Telini L, Barretti P, Caramori J
BMC Nephrol. 2012; 13:80.
PMID: 22867112
PMC: 3489568.
DOI: 10.1186/1471-2369-13-80.
Safe spinal anesthesia in a woman with chronic renal failure and placenta previa.
Zencirci B
Int J Gen Med. 2010; 3:153-6.
PMID: 20689686
PMC: 2915524.
DOI: 10.2147/ijgm.s11421.
Effect of haemodialysis on retinal circulation in patients with end stage renal disease.
Nagaoka T, Takeyama Y, Kanagawa S, Sakagami K, Mori F, Yoshida A
Br J Ophthalmol. 2004; 88(8):1026-9.
PMID: 15258019
PMC: 1772274.
DOI: 10.1136/bjo.2003.039073.
